Banque Pictet & Cie’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,415
Closed -$4.61M 424
2025
Q4
$4.61M Sell
45,415
-65,104
-59% -$5.23M 0.03% 155
2025
Q3
$6.05M Buy
110,519
+4
+0% +$200 0.04% 134
2025
Q2
$5.87M Buy
110,515
+56,661
+105% +$2.88M 0.04% 137
2025
Q1
$2.33M Sell
53,854
-16,839
-24% -$853K 0.02% 200
2024
Q4
$3.97M Sell
70,693
-118,540
-63% -$7.38M 0.03% 176
2024
Q3
$12.9M Buy
189,233
+6,199
+3% +$350K 0.1% 78
2024
Q2
$7.73M Buy
183,034
+69,585
+61% +$3.83M 0.07% 122
2024
Q1
$7.83M Sell
113,449
-77,250
-41% -$4.89M 0.07% 116
2023
Q4
$14.1M Sell
190,699
-81,942
-30% -$5.37M 0.12% 74
2023
Q3
$18.6M Sell
272,641
-22,372
-8% -$1.9M 0.22% 61
2023
Q2
$27.7M Buy
295,013
+2,287
+0.8% +$178K 0.24% 58
2023
Q1
$19.8M Sell
292,726
-44,020
-13% -$2.83M 0.19% 63
2022
Q4
$16.7M Sell
336,746
-85,459
-20% -$3.49M 0.17% 71
2022
Q3
$13.7M Sell
422,205
-1,692
-0.4% -$69.8K 0.15% 80
2022
Q2
$16.7K Sell
423,897
-66,042
-13% -$3.53M 0.17% 74
2022
Q1
$34.3M Buy
489,939
+3,040
+0.6% +$222K 0.26% 49
2021
Q4
$37.9M Buy
486,899
+104,229
+27% +$9.2M 0.28% 51
2021
Q3
$36.5M Sell
382,670
-12,714
-3% -$1.34M 0.38% 41
2021
Q2
$49.1M Buy
395,384
+91,495
+30% +$10.9M 0.55% 29
2021
Q1
$40M Buy
303,889
+80,420
+36% +$11M 0.51% 33
2020
Q4
$29.6M Sell
223,469
-16,223
-7% -$1.96M 0.4% 36
2020
Q3
$24.4M Buy
239,692
+19,734
+9% +$1.7M 0.37% 40
2020
Q2
$19.1M Buy
219,958
+899
+0.4% +$71.8K 0.32% 43
2020
Q1
$12.7M Buy
219,059
+152,714
+230% +$12.4M 0.26% 50
2019
Q4
$6.14M Buy
+66,345
New +$5.83M 0.11% 128

Other funds holding EXAS

Banque Pictet & Cie's EXAS Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 45,415 shares — an estimated $4.61M sold.

Banque Pictet & Cie first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $49.1M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Banque Pictet & Cie reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 45,415 Exact Sciences shares in Q1 2026, an estimated $4.61M.
  • Banque Pictet & Cie first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Banque Pictet & Cie's Exact Sciences position peaked at $49.1M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.